9,393
Total Claims
$973K
Drug Cost
781
Beneficiaries
$1,246
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-72%
Opioid rate vs peers
0.6% vs 2.2% avg
-12%
Cost per patient vs peers
$1,246 vs $1,411 avg
+26%
Brand preference vs peers
13.4% vs 10.6% avg
Opioid Prescribing
0.6%
Opioid Rate
59
Opioid Claims
$1,100
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
87% generic
Brand: 1,253 claims · $797K
Generic: 8,065 claims · $172K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 103 | $147K |
| Empagliflozin | 94 | $110K |
| Dulaglutide | 42 | $67K |
| Apixaban | 50 | $49K |
| Rivaroxaban | 31 | $41K |
| Sitagliptin Phosphate | 35 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 43 | $33K |
| Semaglutide | 13 | $27K |
| Budesonide/Formoterol Fumarate | 37 | $27K |
| Tiotropium Bromide | 18 | $26K |
| Fluticasone/Vilanterol | 38 | $19K |
| Fluticasone/Umeclidin/Vilanter | 13 | $17K |
| Linaclotide | 13 | $17K |
| Insulin Lispro | 11 | $15K |
| Fluticasone Propion/Salmeterol | 13 | $14K |
Prescribing Profile
Patient Profile
74
Avg Age
75%
Female
1.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data